BPTS Biophytis
- 8.220
- 0.0000.00%
Biophytis News
Biophytis Deploys Its Partnership Strategy and Signs Two Contracts With Local Agents in Asia
Biophytis Obtains IND Approval From the FDA to Start Its Phase 2 OBA Study in Obesity
Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris
6-K: Report of foreign private issuer (related to financial reporting)
Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million
Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities
Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by Its Service Provider Seqens
Biophytis Announces Filing of an IND Application With the US FDA for Its Phase 2 Study in Obesity
Combined General Meeting of June 24, 2024
Biophytis Announces the Design of Its Phase 2 OBA Clinical Study in Obesity
Biophytis Is Deploying Its Partnership Strategy in Obesity
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
Optinose OPTN Product Revenue; Biophytis BPTS NASDAQ Delist
Top Premarket Decliners
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Biophytis Announces Transfer of ADSs to OTC Market
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Analysis
Price Target
No Data
No Data